These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5789770)

  • 41. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
    MacKenzie EM; Grant SL; Baker GB; Wood PL
    Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of tranylcypromine and pargyline on indoleamines in brain.
    Tabakoff B; Moses F
    Biochem Pharmacol; 1976 Dec; 25(23):2555-60. PubMed ID: 985576
    [No Abstract]   [Full Text] [Related]  

  • 43. [The modification of the effect of phenelzine, phenylpropylhydrazine and aminooxyacetic acid on the content of gamma-aminobutyric acid in the rat brain by monoamine oxidase inhibitors].
    Matthies H; Popov N
    Acta Biol Med Ger; 1968; 20(3):371-8. PubMed ID: 5725428
    [No Abstract]   [Full Text] [Related]  

  • 44. Deuterium isotope effect of phenelzine on the inhibition of rat liver mitochondrial monoamine oxidase activity.
    Yu PH; Tipton KF
    Biochem Pharmacol; 1989 Dec; 38(23):4245-51. PubMed ID: 2597196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism of tyramine-1-14C by the rat.
    Tacker M; McIsaac WM; Creaven PJ
    Biochem Pharmacol; 1970 Oct; 19(10):2763-73. PubMed ID: 5478585
    [No Abstract]   [Full Text] [Related]  

  • 46. [THE EFFECT OF MONOAMINE OXIDASE INHIBITORS ON THE BODY TEMPERATURE OF RATS].
    SCHMIDT J; FAEHSE C
    Acta Biol Med Ger; 1964; 13():607-14. PubMed ID: 14274077
    [No Abstract]   [Full Text] [Related]  

  • 47. [Enzymatic method for the detection of monoamine oxidase inhibitors].
    Mercier MJ; Curry AS
    Eur J Toxicol; 1971; 4(1):36-8. PubMed ID: 5092664
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of antidepressive substances on monoamine oxidase in vitro and in vivo].
    VITEK V; RYSANEK K
    Cesk Farm; 1962 Oct; 11():399-404. PubMed ID: 13997520
    [No Abstract]   [Full Text] [Related]  

  • 49. Cumulative effects of irreversible MAO inhibitors in vivo.
    Felner AE; Waldmeier PC
    Biochem Pharmacol; 1979 Apr; 28(7):995-1002. PubMed ID: 444293
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of various monoamine oxidase inhibitors on the structure of the sleep-wakefulness cycle of the cat].
    Oniani TN; Akhvlediani GR
    Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):332-7. PubMed ID: 3582693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoamine oxidase dependent labeling in vivo of mouse brain by 14C-serotonin.
    Alivisatos SG; Ungar F; Parmar SS; Seth PK
    Biochem Pharmacol; 1968 Sep; 17(9):1993-5. PubMed ID: 5688280
    [No Abstract]   [Full Text] [Related]  

  • 53. Detection and identification of monoamine oxidase inhibitors in biological samples.
    Curry AS; Mercier M
    Nature; 1970 Oct; 228(5268):281-2. PubMed ID: 5479525
    [No Abstract]   [Full Text] [Related]  

  • 54. Accumulation of [14C]5-hydroxytryptamine in the pregnant rat uterus after treatment with a monoamine oxidase inhibitor.
    Koren Z; Pfeifer Y; Sulman FG
    J Endocrinol; 1969 Mar; 43(3):471-5. PubMed ID: 5779619
    [No Abstract]   [Full Text] [Related]  

  • 55. Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors.
    Gillman PK
    J Clin Psychopharmacol; 2011 Feb; 31(1):66-74. PubMed ID: 21192146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipomobilization effect of nonhydrazine type of monoamine oxidase inhibitors.
    Kypson J; Lipton R; Horowitz W; Nahas GG
    Biochem Pharmacol; 1969 Oct; 18(10):2566-72. PubMed ID: 5408606
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines.
    GEY KF; PLETSCHER A; BURKARD W
    Ann N Y Acad Sci; 1963 Jul; 107():1147-51. PubMed ID: 13947443
    [No Abstract]   [Full Text] [Related]  

  • 58. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
    Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some antagonists of the monoamine oxidase inhibitors.
    HORITA A
    Ann N Y Acad Sci; 1963 Jul; 107():951-7. PubMed ID: 13954907
    [No Abstract]   [Full Text] [Related]  

  • 60. [ELECTROENCEPHALOGRAPHIC CONTRIBUTION TO THE STUDY OF MONOAMINE OXIDASE INHIBITING DRUGS: CHANGES INDUCED IN EXPERIMENTAL EPILEPSY IN RABBITS].
    LUCIONI R; PENATI G; INVERNIZZI G
    Riv Neurol; 1964; 34():368-74. PubMed ID: 14208879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.